← FDA Drug Approvals (Drugs@FDA)

AZACITIDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD VI · Approved 2024-10-15

Drug application

FDA Application #

ANDA215765

Application type

Abbreviated New Drug Application (Generic)

Brand name

AZACITIDINE

Generic name

AZACITIDINE

Active ingredients

AZACITIDINE

Dosage form

POWDER

Route

INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

HETERO LABS LTD VI

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2024-10-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown